J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M500365-JLR200 on October 12, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M500365-JLR200v1
47/1/181    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Botolin, D.
Right arrow Articles by Jump, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Botolin, D.
Right arrow Articles by Jump, D. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 47, 181-192, January 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways

Daniela Botolin, Yun Wang, Barbara Christian and Donald B. Jump1

Departments of Physiology, Biochemistry, and Molecular Biology, Michigan State University, East Lansing, MI 48824

Published, JLR Papers in Press, October 12, 2005.

1 To whom correspondence should be addressed. e-mail: jump{at}msu.edu

Insulin induces and dietary n-3 PUFAs suppress hepatic de novo lipogenesis by controlling sterol-regulatory element binding protein-1 nuclear abundance (nSREBP-1). Our goal was to define the mechanisms involved in this regulatory process. Insulin treatment of rat primary hepatocytes rapidly augments nSREBP-1 and mRNASREBP-1c while suppressing mRNAInsig-2 but not mRNAInsig-1. These events are preceded by rapid but transient increases in Akt and Erk phosphorylation. Removal of insulin from hepatocytes leads to a rapid decline in nSREBP-1 [half-time (T1/2) ~ 10 h] that is abrogated by inhibitors of 26S proteasomal degradation. 22:6,n-3, the major n-3 PUFA accumulating in livers of fish oil-fed rats, suppresses hepatocyte levels of nSREBP-1, mRNASREBP-1c, and mRNAInsig-2 but modestly and transiently induces mRNAInsig-1. More importantly, 22:6,n-3 accelerates the disappearance of hepatocyte nSREBP-1 (T1/2 ~ 4 h) through a 26S proteasome-dependent process. 22:6,n-3 has minimal effects on microsomal SREBP-1 and sterol-regulatory element binding protein cleavage-activating protein or nuclear SREBP-2. 22:6,n-3 transiently inhibits insulin-induced Akt phosphorylation but induces Erk phosphorylation. Inhibitors of Erk phosphorylation, but not overexpressed constitutively active Akt, rapidly attenuate 22:6,n-3 suppression of nSREBP-1. Thus, 22:6,n-3 suppresses hepatocyte nSREBP-1 through 26S proteasome- and Erk-dependent pathways. These studies reveal a novel mechanism for n-3 PUFA regulation of hepatocyte nSREBP-1 and lipid metabolism.

Supplementary key words sterol regulatory element binding protein-1 • Insig-1 • Insig-2

Abbreviations: ER, endoplasmic reticulum; LXR, liver X receptor; MEK, mitogen-activated protein kinase kinase; PI3K, phosphatidylinositol 3-kinase; SCAP, sterol-regulatory element binding protein cleavage-activating protein; SREBP, sterol-regulatory element binding protein; T1/2, half-time


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
Y. Wang, M. Torres-Gonzalez, S. Tripathy, D. Botolin, B. Christian, and D. B. Jump
Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition
J. Lipid Res., July 1, 2008; 49(7): 1538 - 1552.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. H. Chen, P. H. Wang, B. H. Liu, H. H. Hsu, H. J. Mersmann, and S. T. Ding
Serum Amyloid A Protein Regulates the Expression of Porcine Genes Related to Lipid Metabolism
J. Nutr., April 1, 2008; 138(4): 674 - 679.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. E. Bauman, J. W. Perfield II, K. J. Harvatine, and L. H. Baumgard
Regulation of Fat Synthesis by Conjugated Linoleic Acid: Lactation and the Ruminant Model
J. Nutr., February 1, 2008; 138(2): 403 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Talukdar, S. Bhatnagar, S. Dridi, and F. B. Hillgartner
Chenodeoxycholic acid suppresses the activation of acetyl-coenzyme A carboxylase-{alpha} gene transcription by the liver X receptor agonist T0-901317
J. Lipid Res., December 1, 2007; 48(12): 2647 - 2663.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Calviello, F. Resci, S. Serini, E. Piccioni, A. Toesca, A. Boninsegna, G. Monego, F. O. Ranelletti, and P. Palozza
Docosahexaenoic acid induces proteasome-dependent degradation of {beta}-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2
Carcinogenesis, June 1, 2007; 28(6): 1202 - 1209.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Yan, M. Lehto, L. Rasilainen, J. Metso, C. Ehnholm, S. Yla-Herttuala, M. Jauhiainen, and V. M. Olkkonen
Oxysterol Binding Protein Induces Upregulation of SREBP-1c and Enhances Hepatic Lipogenesis
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1108 - 1114.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Igarashi, J. C. DeMar Jr., K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport
Upregulated liver conversion of {alpha}-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet
J. Lipid Res., January 1, 2007; 48(1): 152 - 164.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Wang, D. Botolin, J. Xu, B. Christian, E. Mitchell, B. Jayaprakasam, M. Nair, J. M. Peters, J. Busik, L. K. Olson, et al.
Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity
J. Lipid Res., September 1, 2006; 47(9): 2028 - 2041.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Xu, B. Christian, and D. B. Jump
Regulation of Rat Hepatic L-Pyruvate Kinase Promoter Composition and Activity by Glucose, n-3 Polyunsaturated Fatty Acids, and Peroxisome Proliferator-activated Receptor-{alpha} Agonist
J. Biol. Chem., July 7, 2006; 281(27): 18351 - 18362.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Dentin, P.-D. Denechaud, F. Benhamed, J. Girard, and C. Postic
Hepatic Gene Regulation by Glucose and Polyunsaturated Fatty Acids: A Role for ChREBP
J. Nutr., May 1, 2006; 136(5): 1145 - 1149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.